Phillip MD Et al Frost's Net Worth

$483 Million

Who is Phillip MD Et al Frost?

Phillip MD Et al Frost has an estimated net worth of $483 Million. This is based on reported shares across multiple companies, which include NON INVASIVE MONITORING SYSTEMS INC /FL/, LADENBURG THALMANN FINANCIAL SERVICES INC., GlenRose Instruments Inc., Cocrystal Pharma, Inc., Red Violet, Inc., OPKO HEALTH, INC., VECTOR GROUP LTD, BioCardia, Inc., Protalix BioTherapeutics, Inc., PASSPORT POTASH INC, NORTHROP GRUMMAN CORP /DE/, ChromaDex Corp., TRANSENTERIX INC., Fluent, Inc., Sevion Therapeutics, Inc., PROLOR Biotech, Inc., NextPlat Corp, Castle Brands Inc, VAPORIN, INC., Ideation Acquisition Corp., Winston Pharmaceuticals, Inc., NOCOPI TECHNOLOGIES INC/MD/, IVAX DIAGNOSTICS INC, IVAX CORP, and CONTINUCARE CORP.

SEC CIK

Phillip MD Et al Frost's CIK is 0000898860

Past Insider Trading and Trends

2014 was Phillip MD Et al Frost's most active year for acquiring shares with 2100 total transactions. Phillip MD Et al Frost's most active month to acquire stocks was the month of February. 2009 was Phillip MD Et al Frost's most active year for disposing of shares, totalling 341 transactions. Phillip MD Et al Frost's most active month to dispose stocks was the month of July. 2011 saw Phillip MD Et al Frost paying a total of $148,694,358.32 for 39,611,893.164 shares, this is the most they've acquired in one year. In 2018 Phillip MD Et al Frost cashed out on 69,161,944 shares for a total of $153,156,023.36, their largest year based on trade value.